Page last updated: 2024-10-25

desipramine and MS (Multiple Sclerosis)

desipramine has been researched along with MS (Multiple Sclerosis) in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"In a double-blind clinical trial involving 28 patients with multiple sclerosis and major depressive disorder, 14 patients were randomly assigned to a 5-week trial of desipramine and individual psychotherapy and 14 to placebo plus psychotherapy."5.06Antidepressant pharmacotherapy of depression associated with multiple sclerosis. ( Schiffer, RB; Wineman, NM, 1990)
"Both desipramine and paroxetine show a trend towards efficacy in depression in MS the short term, but both treatments were associated with adverse effects, with significantly more patients treated with paroxetine suffering from nausea or headache."4.87Pharmacologic treatment of depression in multiple sclerosis. ( De Keyser, J; Glazenborg, A; Koch, MW; Mostert, J; Uyttenboogaart, M, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, MW1
Glazenborg, A1
Uyttenboogaart, M1
Mostert, J1
De Keyser, J1
Schiffer, RB1
Wineman, NM1

Reviews

1 review available for desipramine and MS (Multiple Sclerosis)

ArticleYear
Pharmacologic treatment of depression in multiple sclerosis.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Adult; Antidepressive Agents; Depression; Desipramine; Humans; Multiple Sclerosis; Paroxetine; Rando

2011

Trials

1 trial available for desipramine and MS (Multiple Sclerosis)

ArticleYear
Antidepressant pharmacotherapy of depression associated with multiple sclerosis.
    The American journal of psychiatry, 1990, Volume: 147, Issue:11

    Topics: Adult; Aged; Depressive Disorder; Desipramine; Double-Blind Method; Female; Humans; Male; Middle Age

1990